What is the role of the Renin-Angiotensin-Aldosterone System (RAAS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Renin-Angiotensin-Aldosterone System (RAAS)

The RAAS is a hormonal cascade that regulates blood pressure and fluid-electrolyte balance through a negative feedback loop involving renin, angiotensin II, and aldosterone, with downstream effects on renal sodium and water reabsorption, systemic arteriolar vasoconstriction, and sympathetic nervous system activation. 1

Primary Physiological Functions

Blood Pressure Regulation

  • The RAAS cascade initiates in response to three triggers: decreases in blood pressure, reductions in sodium chloride delivery to the macula densa of the distal convoluted tubule, and stimulation of renal sympathetic nerves 1
  • Renin is secreted by the kidneys and cleaves hepatic angiotensinogen to form angiotensin I 2
  • Angiotensin-converting enzyme (ACE) then converts angiotensin I to angiotensin II, the primary active product 1, 2

Angiotensin II Actions

Angiotensin II elevates blood pressure through multiple mechanisms:

  • Increases sodium reabsorption in the proximal convoluted tubule 1
  • Promotes systemic arteriolar vasoconstriction 1
  • Activates the sympathetic nervous system 1
  • Increases thirst 1
  • Stimulates aldosterone release from the adrenal cortex 1
  • Stimulates antidiuretic hormone release from the pituitary 1
  • Promotes catecholamine release from the adrenal medulla and prejunctional nerve endings 2

Aldosterone and Fluid Balance

  • Aldosterone directly stimulates renal sodium and fluid retention to increase blood volume 1
  • This completes the negative feedback loop, as angiotensin II also inhibits renin release 2

Broader Physiological Roles

Tissue-Level Functions

  • RAAS functions as both a circulating hormone system and a local tissue hormone system (acting as a local mediator, neurotransmitter, or neuromodulator in the CNS) 3
  • Every organ is affected by RAAS activation, influencing cell proliferation, inflammation, and fibrosis 4

Pregnancy-Specific Functions

  • RAAS is crucial for cardiovascular and kidney development in the fetus 1
  • Circulating and local tissue angiotensin II plays key roles in placentation, including trophoblast invasion and migration, as well as spiral artery remodeling 1
  • ACE is concentrated in fetal endothelial cells throughout pregnancy, favoring enhanced angiotensin II production in placental vessels to support angiogenesis and fetal perfusion 1, 5

Clinical Significance

Pathophysiological Role

  • Dysregulation of RAAS plays an important role in the pathogenesis of hypertension, cardiovascular disease, renal disorders, and atherosclerosis 3, 6, 7
  • RAAS should be constantly suppressed, and any degree of excessive activity may lead to hypertension and associated target organ damage 8

Therapeutic Targeting

  • RAAS is an important target for five distinctive classes of antihypertensive drugs: beta blockers, renin inhibitors, ACE inhibitors, angiotensin receptor blockers (ARBs), and aldosterone inhibitors 8
  • Pharmacological interruption of RAAS has proven beneficial in treating hypertension, congestive heart failure, myocardial infarction, and diabetic nephropathy 3

Compensatory Mechanisms

Feedback Loop Dynamics

  • All agents that inhibit RAAS suppress the negative feedback loop, leading to a compensatory rise in plasma renin concentration 2
  • With ACE inhibitors and ARBs, this results in increased plasma renin activity 2
  • With direct renin inhibitors like aliskiren, the effect of increased renin levels is blocked, so plasma renin activity, angiotensin I, and angiotensin II are all reduced 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017

Guideline

Angiotensin-Converting Enzyme Production and Regulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.

The Journal of the Association of Physicians of India, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.